The Effects of the Continuous Renal Replacement therapy with alprostail in the treatment of the late-stage severe hepatitis with hepatorenal syndrome

TANG Liang-Kai

Welcome to Labeled Immunoassays and Clinical Medicine website!
Labeled Immunoassays and Clinical Medicine ›› 2015, Vol. 22 ›› Issue (6) : 517. DOI: 10.11748/bjmy.issn.1006-1703.2015.06.013

The Effects of the Continuous Renal Replacement therapy with alprostail in the treatment of the late-stage severe hepatitis with hepatorenal syndrome

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2015, 22(6): 517 https://doi.org/10.11748/bjmy.issn.1006-1703.2015.06.013

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/